# Corgentech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corgentech

- Industry: Pharmaceuticals
- Headquarters: South San Francisco, US
- Total disclosed funding: $50M
- Latest round: Series C (Jul 16, 2002)
- Investors on record: 8

## About

Founded in 1999 and based in California, US, Corgentech is a biotechnology company focused on the development of a class of therapeutics called transcription factor decoys or TF Decoys.

## Funding rounds

- Series C, Jul 16, 2002, $50M — Alta Partners, InterWest Partners, Temasek Holdings, HBM Partners, CDIB BioScience Venture Management, JP Morgan Asset Management, Bear Stearns Health Innoventures, PRM Ventures

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series C
- Temasek Holdings — Series C
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C
- CDIB BioScience Venture Management (https://capitalatlas.ai/funds/cdib-bioscience-venture-management) — Series C
- JP Morgan Asset Management (https://capitalatlas.ai/funds/jp-morgan-asset-management) — Series C
- Bear Stearns Health Innoventures (https://capitalatlas.ai/funds/bear-stearns-health-innoventures) — Series C
- PRM Ventures — Series C